Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Triple Branch”

182 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 182 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT05953168
What this trial is testing

T-DXd in the First-Line Treatment of Locally Advanced or Metastatic TNBC-LAR HER2-low Patients

Who this might be right for
Triple-Negative Breast Cancer
Fudan University 69
Testing effectiveness (Phase 2)Looking for participantsNCT06845319
What this trial is testing

Anthracycline-Free Neoadjuvant Chemoimmunotherapy for Triple Negative Breast Cancer Patients

Who this might be right for
Triple Negative Breast Cancer
Medical University of South Carolina 43
Early research (Phase 1)Study completedNCT01920061
What this trial is testing

PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC)

Who this might be right for
Neoplasm
Pfizer 110
Not applicableStudy completedNCT01299103
What this trial is testing

Safety and Efficacy of Single Therapy Versus Double and Triple Therapy of the Pellevé™ Wrinkle Treatment System for the Treatment of Moderate Facial Wrinkles

Who this might be right for
Appearance of Facial Wrinkles
Ellman International 40
Testing effectiveness (Phase 2)UnknownNCT03692689
What this trial is testing

Safety and Efficacy of SCT200 in Patients With Relapsed or Metastatic Triple Receptor Negative Breast Cancer

Who this might be right for
Triple Negative Breast Neoplasms
Sinocelltech Ltd. 30
Testing effectiveness (Phase 2)UnknownNCT05214339
What this trial is testing

A Trial of Hepatic Arterial Infusion Combined With Bevacizumab and Sintilimab for Unresectable A-staged Hepatocellular Carcinoma in BCLC Classification (D-TRIPLET)

Who this might be right for
Unresectable Hepatocellular CarcinomaHepatocellular Carcinoma by BCLC Stage
Sun Yat-sen University 30
Post-approval studies (Phase 4)Study completedNCT04853446
What this trial is testing

Oral Dexamethasone as an Adjunct to a Brachial Plexus Block in Patients Undergoing Orthopaedic Surgery of the Forearm and Hand

Who this might be right for
Anesthesia, Local
Zealand University Hospital 180
Not applicableStudy completedNCT02896777
What this trial is testing

Triple-arm pH Comparison

Who this might be right for
In Vitro Fertilisation Outcome
Ibn Sina Hospital 2,273
Testing effectiveness (Phase 2)Active Not RecruitingNCT05451849
What this trial is testing

A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer

Who this might be right for
MesotheliomaMesotheliomas PleuralMesothelioma, Malignant+14 more
TCR2 Therapeutics 6
Large-scale testing (Phase 3)Study completedNCT01867164
What this trial is testing

Compare Efficacy and Safety of an Ovule Containing Terconazole, Clindamycin and Fluocinolone Versus an Ovule Containing Metronidazole, Nystatin and Fluocinolone in the Treatment of Secondary Vulvar/ or Vaginal Symptoms of Infectious Vaginitis/ and Infectious Vaginosis

Who this might be right for
VaginitisInfectious Vaginosis
Janssen-Cilag, S.A. 160
Early research (Phase 1)Study completedNCT03514732
What this trial is testing

Study to Evaluate Improvements of the Quality of Sleep With NOVANUIT® Triple Action in Healthy Volunteers With Sleep Disorders

Who this might be right for
Sleep Disorder (Healthy Volunteers)
Sanofi 40
Testing effectiveness (Phase 2)UnknownNCT05747313
What this trial is testing

Chidamide in Combination With Vincristine Metronomic Chemotherapy for Advanced Triple-negative Breast Cancer

Who this might be right for
Breast CancerChemotherapy Effect
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 40
Post-approval studies (Phase 4)Not Yet RecruitingNCT05843292
What this trial is testing

Short-term Sintilimab in Combination With Taxane and Carboplatin for Neoadjuvant Therapy in Triple-negative Breast Cancer

Who this might be right for
Triple-negative Breast Cancer
Shanghai Jiao Tong University School of Medicine 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT03090165
What this trial is testing

Ribociclib and Bicalutamide in AR+ TNBC

Who this might be right for
Triple Negative Breast Cancer
Kari Wisinski 37
Testing effectiveness (Phase 2)Ended earlyNCT02347163
What this trial is testing

Pre-operative Zoledronate in Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
Mario Negri Institute for Pharmacological Research 22
Testing effectiveness (Phase 2)WithdrawnNCT05512182
What this trial is testing

Efficacy of Triplet Combination With Pembrolizumab, Neratinib, and Paclitaxel as a Second Line Treatment in Recurrent/Advanced Gastric Cancer Having Somatic Human Epidermal Growth Factor Receptor Family (EGFR, HER2, HER3, HER4) Mutations or HER2 Amplification/Overexpression

Who this might be right for
Recurrent/Advanced Gastric Cancer
Yonsei University
Testing effectiveness (Phase 2)WithdrawnNCT04456023
What this trial is testing

Study of Tisagenlecleucel in Chinese Adult Patients With Relapsed or Refractory Diffuse Large B-cell Non-Hodgkin Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B-Cell Lymphoma (DLBCL)
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Looking for participantsNCT03213041
What this trial is testing

Pembrolizumab and Carboplatin in Treating Patients With Circulating Tumor Cells Positive Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor NegativeEstrogen Receptor PositiveHER2/Neu Negative+4 more
Northwestern University 100
Not applicableActive Not RecruitingNCT04993625
What this trial is testing

Selective Avoidance of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy In HER-2 Positive/Triple Negative Breast Cancer Patients With Excellent Radiologic Response to the Breast and Axilla, Prospective, Multi-center, Single-arm (ASLAN) Study

Who this might be right for
Breast Cancer
Jeong Eon Lee 178
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06210438
What this trial is testing

SHR-A1921 Combined With Bevacizumab in Triple-negative Breast Cancer With Brain Metastases

Who this might be right for
TNBCBrain Metastasis
Fudan University 24
Load More Results